MASS vs. AEHR, QTRX, QSI, NAUT, KEQU, FEIM, RPID, SEER, AKYA, and INTT
Should you be buying 908 Devices stock or one of its competitors? The main competitors of 908 Devices include Aehr Test Systems (AEHR), Quanterix (QTRX), Quantum-Si (QSI), Nautilus Biotechnology (NAUT), Kewaunee Scientific (KEQU), Frequency Electronics (FEIM), Rapid Micro Biosystems (RPID), Seer (SEER), Akoya Biosciences (AKYA), and inTEST (INTT). These companies are all part of the "measuring and control equipment" industry.
908 Devices vs.
Aehr Test Systems (NASDAQ:AEHR) and 908 Devices (NASDAQ:MASS) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation, institutional ownership and community ranking.
Aehr Test Systems received 113 more outperform votes than 908 Devices when rated by MarketBeat users. Likewise, 58.15% of users gave Aehr Test Systems an outperform vote while only 54.29% of users gave 908 Devices an outperform vote.
Aehr Test Systems has higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than Aehr Test Systems, indicating that it is currently the more affordable of the two stocks.
Aehr Test Systems has a beta of 1.81, suggesting that its stock price is 81% more volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.99, suggesting that its stock price is 1% less volatile than the S&P 500.
In the previous week, Aehr Test Systems had 4 more articles in the media than 908 Devices. MarketBeat recorded 6 mentions for Aehr Test Systems and 2 mentions for 908 Devices. Aehr Test Systems' average media sentiment score of 0.73 beat 908 Devices' score of 0.30 indicating that Aehr Test Systems is being referred to more favorably in the media.
Aehr Test Systems currently has a consensus target price of $25.00, suggesting a potential upside of 118.72%. 908 Devices has a consensus target price of $5.33, suggesting a potential upside of 110.39%. Given Aehr Test Systems' higher probable upside, equities research analysts clearly believe Aehr Test Systems is more favorable than 908 Devices.
69.7% of Aehr Test Systems shares are held by institutional investors. Comparatively, 88.1% of 908 Devices shares are held by institutional investors. 6.2% of Aehr Test Systems shares are held by company insiders. Comparatively, 27.7% of 908 Devices shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Aehr Test Systems has a net margin of 43.41% compared to 908 Devices' net margin of -109.11%. Aehr Test Systems' return on equity of 21.09% beat 908 Devices' return on equity.
Summary
Aehr Test Systems beats 908 Devices on 14 of the 17 factors compared between the two stocks.
Get 908 Devices News Delivered to You Automatically
Sign up to receive the latest news and ratings for MASS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
908 Devices Competitors List
Related Companies and Tools
This page (NASDAQ:MASS) was last updated on 2/22/2025 by MarketBeat.com Staff